Our results highlight the critical role of SHH signaling in human pancreatic CSCs and the possibility of targeting Gli1 and Gli2 activator functions using GDC-0449 in pancreatic cancer stem cells. This evidence concerns the gene GLI1 and familial pancreatic carcinoma.